Logo

fraud

Analysis of CMS Data Raises Alarm on Potential Genetic Testing Fraud
Premium

High payment rates for tests for rare disorders in regions covered by two Medicare Administrative Contractors could spark debate about genetic testing fraud.

Arrayit President Found Guilty in COVID-19, Allergy Testing Scheme

Arrayit President Mark Schena faces prison for orchestrating an illegal kickback and healthcare fraud scheme, among other things.

Myriad Genetics Settles Anti-Kickback Lawsuit Related to Vectra DA

Myriad will pay $45.25 million to the federal and California state governments and $2.75 million to the whistleblower in exchange for dismissal of the case and all claims against it.

Florida Lab Owner Pleads Guilty to $6.9M COVID-19 False Billing Scheme

The owner was accused of bundling COVID-19 testing with other medically unnecessary forms of testing.

HHS OIG Finds Sharp Rise in Medicare Payments for Genetic Tests

Medicare payments for genetic tests and the number of such tests rose sharply, as did the number of labs receiving more than $1 million in reimbursements for such tests.

Sep 5, 2021

UK Government Investigates COVID-19 Testing Firm

Sep 1, 2021

Lab Owner Pleads Guilty to $73M Scheme to Defraud Medicare

Jan 11, 2021

BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud

Mar 22, 2020

FDA Warns Consumers About Fraudulent At-Home COVID-19 Test Kits

Oct 10, 2019

UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case

Jul 19, 2019

Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

Feb 12, 2019

GenomeDx Biosciences to Pay $2M to Settle Allegations of Improper Medicare Billing

Oct 8, 2018

Investors Sue Illumina for Fraud in Connection With Q3 2016 Earnings Results

Sep 28, 2017

Alere Settles With SEC for $13M

May 15, 2017

OIG Tracking Fraud, Inappropriate Use Within Rapidly Growing Genetic Testing Industry
Premium

Jun 23, 2015

Despite Retraction, Researchers Still Concerned Sequencing Study Data was Fabricated
Premium

Apr 2, 2015

Federal Court OKs Celera's $23M Settlement with Former Shareholders

Feb 9, 2012

Class Action Lawsuits Filed Against China Medical Technologies Alleging Artificial Stock Inflation

Sep 2, 2011

Sequenom Avoids Fine from SEC, Enters Cease-and-Desist Order

Feb 25, 2011

Signal Genetics Adds Precision Therapeutics to Suit

Jul 14, 2010

Former Sequenom Exec Pleads Guilty; Sentencing Scheduled for August

Feb 24, 2010

Transgenomic Files Suit Against Power3 Alleging Fraud, Slander

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.